Global Vaccine for Influenza Supply, Demand and Key Producers, 2023-2029
The global Vaccine for Influenza market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report studies the global Vaccine for Influenza production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaccine for Influenza, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine for Influenza that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaccine for Influenza total production and demand, 2018-2029, (M Units)
Global Vaccine for Influenza total production value, 2018-2029, (USD Million)
Global Vaccine for Influenza production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Vaccine for Influenza consumption by region & country, CAGR, 2018-2029 & (M Units)
U.S. VS China: Vaccine for Influenza domestic production, consumption, key domestic manufacturers and share
Global Vaccine for Influenza production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Units)
Global Vaccine for Influenza production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Vaccine for Influenza production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Units).
This reports profiles key players in the global Vaccine for Influenza market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine for Influenza market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaccine for Influenza Market, By Region:
%lI%United States
%lI%China
%lI%Europe
%lI%Japan
%lI%South Korea
%lI%ASEAN
%lI%India
%lI%Rest of World
Global Vaccine for Influenza Market, Segmentation by Type
%lI%Trivalent Influenza Vaccine
%lI%Quadrivalent Influenza Vaccine
Global Vaccine for Influenza Market, Segmentation by Application
%lI%6 Months to 3 Years
%lI%> 3 Years
Companies Profiled:
%lI%Sanofi
%lI%CSL
%lI%GSK
%lI%Viatris
%lI%AstraZeneca
%lI%Hualan Bio
%lI%Changchun Institute of Biological
%lI%Sinovac
%lI%BCHT
%lI%Jiangsu GDK
%lI%KM Biologics
Key Questions Answered
1. How big is the global Vaccine for Influenza market?
2. What is the demand of the global Vaccine for Influenza market?
3. What is the year over year growth of the global Vaccine for Influenza market?
4. What is the production and production value of the global Vaccine for Influenza market?
5. Who are the key producers in the global Vaccine for Influenza market?
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report studies the global Vaccine for Influenza production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaccine for Influenza, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine for Influenza that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaccine for Influenza total production and demand, 2018-2029, (M Units)
Global Vaccine for Influenza total production value, 2018-2029, (USD Million)
Global Vaccine for Influenza production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Vaccine for Influenza consumption by region & country, CAGR, 2018-2029 & (M Units)
U.S. VS China: Vaccine for Influenza domestic production, consumption, key domestic manufacturers and share
Global Vaccine for Influenza production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Units)
Global Vaccine for Influenza production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Units)
Global Vaccine for Influenza production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Units).
This reports profiles key players in the global Vaccine for Influenza market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine for Influenza market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaccine for Influenza Market, By Region:
%lI%United States
%lI%China
%lI%Europe
%lI%Japan
%lI%South Korea
%lI%ASEAN
%lI%India
%lI%Rest of World
Global Vaccine for Influenza Market, Segmentation by Type
%lI%Trivalent Influenza Vaccine
%lI%Quadrivalent Influenza Vaccine
Global Vaccine for Influenza Market, Segmentation by Application
%lI%6 Months to 3 Years
%lI%> 3 Years
Companies Profiled:
%lI%Sanofi
%lI%CSL
%lI%GSK
%lI%Viatris
%lI%AstraZeneca
%lI%Hualan Bio
%lI%Changchun Institute of Biological
%lI%Sinovac
%lI%BCHT
%lI%Jiangsu GDK
%lI%KM Biologics
Key Questions Answered
1. How big is the global Vaccine for Influenza market?
2. What is the demand of the global Vaccine for Influenza market?
3. What is the year over year growth of the global Vaccine for Influenza market?
4. What is the production and production value of the global Vaccine for Influenza market?
5. Who are the key producers in the global Vaccine for Influenza market?
1 SUPPLY SUMMARY
1.1 Vaccine for Influenza Introduction
1.2 World Vaccine for Influenza Supply & Forecast
1.2.1 World Vaccine for Influenza Production Value (2018 & 2022 & 2029)
1.2.2 World Vaccine for Influenza Production (2018-2029)
1.2.3 World Vaccine for Influenza Pricing Trends (2018-2029)
1.3 World Vaccine for Influenza Production by Region (Based on Production Site)
1.3.1 World Vaccine for Influenza Production Value by Region (2018-2029)
1.3.2 World Vaccine for Influenza Production by Region (2018-2029)
1.3.3 World Vaccine for Influenza Average Price by Region (2018-2029)
1.3.4 North America Vaccine for Influenza Production (2018-2029)
1.3.5 Europe Vaccine for Influenza Production (2018-2029)
1.3.6 China Vaccine for Influenza Production (2018-2029)
1.3.7 Japan Vaccine for Influenza Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaccine for Influenza Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaccine for Influenza Major Market Trends
2 DEMAND SUMMARY
2.1 World Vaccine for Influenza Demand (2018-2029)
2.2 World Vaccine for Influenza Consumption by Region
2.2.1 World Vaccine for Influenza Consumption by Region (2018-2023)
2.2.2 World Vaccine for Influenza Consumption Forecast by Region (2024-2029)
2.3 United States Vaccine for Influenza Consumption (2018-2029)
2.4 China Vaccine for Influenza Consumption (2018-2029)
2.5 Europe Vaccine for Influenza Consumption (2018-2029)
2.6 Japan Vaccine for Influenza Consumption (2018-2029)
2.7 South Korea Vaccine for Influenza Consumption (2018-2029)
2.8 ASEAN Vaccine for Influenza Consumption (2018-2029)
2.9 India Vaccine for Influenza Consumption (2018-2029)
3 WORLD VACCINE FOR INFLUENZA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vaccine for Influenza Production Value by Manufacturer (2018-2023)
3.2 World Vaccine for Influenza Production by Manufacturer (2018-2023)
3.3 World Vaccine for Influenza Average Price by Manufacturer (2018-2023)
3.4 Vaccine for Influenza Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vaccine for Influenza Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vaccine for Influenza in 2022
3.5.3 Global Concentration Ratios (CR8) for Vaccine for Influenza in 2022
3.6 Vaccine for Influenza Market: Overall Company Footprint Analysis
3.6.1 Vaccine for Influenza Market: Region Footprint
3.6.2 Vaccine for Influenza Market: Company Product Type Footprint
3.6.3 Vaccine for Influenza Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vaccine for Influenza Production Value Comparison
4.1.1 United States VS China: Vaccine for Influenza Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Vaccine for Influenza Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Vaccine for Influenza Production Comparison
4.2.1 United States VS China: Vaccine for Influenza Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaccine for Influenza Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Vaccine for Influenza Consumption Comparison
4.3.1 United States VS China: Vaccine for Influenza Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Vaccine for Influenza Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Vaccine for Influenza Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vaccine for Influenza Production Value (2018-2023)
4.4.3 United States Based Manufacturers Vaccine for Influenza Production (2018-2023)
4.5 China Based Vaccine for Influenza Manufacturers and Market Share
4.5.1 China Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vaccine for Influenza Production Value (2018-2023)
4.5.3 China Based Manufacturers Vaccine for Influenza Production (2018-2023)
4.6 Rest of World Based Vaccine for Influenza Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vaccine for Influenza Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Vaccine for Influenza Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaccine for Influenza Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Trivalent Influenza Vaccine
5.2.2 Quadrivalent Influenza Vaccine
5.3 Market Segment by Type
5.3.1 World Vaccine for Influenza Production by Type (2018-2029)
5.3.2 World Vaccine for Influenza Production Value by Type (2018-2029)
5.3.3 World Vaccine for Influenza Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaccine for Influenza Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 6 Months to 3 Years
6.2.2 > 3 Years
6.3 Market Segment by Application
6.3.1 World Vaccine for Influenza Production by Application (2018-2029)
6.3.2 World Vaccine for Influenza Production Value by Application (2018-2029)
6.3.3 World Vaccine for Influenza Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Vaccine for Influenza Product and Services
7.1.4 Sanofi Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Vaccine for Influenza Product and Services
7.2.4 CSL Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Vaccine for Influenza Product and Services
7.3.4 GSK Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Vaccine for Influenza Product and Services
7.4.4 Viatris Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Vaccine for Influenza Product and Services
7.5.4 AstraZeneca Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Vaccine for Influenza Product and Services
7.6.4 Hualan Bio Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Vaccine for Influenza Product and Services
7.7.4 Changchun Institute of Biological Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Vaccine for Influenza Product and Services
7.8.4 Sinovac Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 BCHT
7.9.1 BCHT Details
7.9.2 BCHT Major Business
7.9.3 BCHT Vaccine for Influenza Product and Services
7.9.4 BCHT Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BCHT Recent Developments/Updates
7.9.6 BCHT Competitive Strengths & Weaknesses
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Details
7.10.2 Jiangsu GDK Major Business
7.10.3 Jiangsu GDK Vaccine for Influenza Product and Services
7.10.4 Jiangsu GDK Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu GDK Recent Developments/Updates
7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
7.11 KM Biologics
7.11.1 KM Biologics Details
7.11.2 KM Biologics Major Business
7.11.3 KM Biologics Vaccine for Influenza Product and Services
7.11.4 KM Biologics Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 KM Biologics Recent Developments/Updates
7.11.6 KM Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaccine for Influenza Industry Chain
8.2 Vaccine for Influenza Upstream Analysis
8.2.1 Vaccine for Influenza Core Raw Materials
8.2.2 Main Manufacturers of Vaccine for Influenza Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Vaccine for Influenza Production Mode
8.6 Vaccine for Influenza Procurement Model
8.7 Vaccine for Influenza Industry Sales Model and Sales Channels
8.7.1 Vaccine for Influenza Sales Model
8.7.2 Vaccine for Influenza Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Vaccine for Influenza Introduction
1.2 World Vaccine for Influenza Supply & Forecast
1.2.1 World Vaccine for Influenza Production Value (2018 & 2022 & 2029)
1.2.2 World Vaccine for Influenza Production (2018-2029)
1.2.3 World Vaccine for Influenza Pricing Trends (2018-2029)
1.3 World Vaccine for Influenza Production by Region (Based on Production Site)
1.3.1 World Vaccine for Influenza Production Value by Region (2018-2029)
1.3.2 World Vaccine for Influenza Production by Region (2018-2029)
1.3.3 World Vaccine for Influenza Average Price by Region (2018-2029)
1.3.4 North America Vaccine for Influenza Production (2018-2029)
1.3.5 Europe Vaccine for Influenza Production (2018-2029)
1.3.6 China Vaccine for Influenza Production (2018-2029)
1.3.7 Japan Vaccine for Influenza Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaccine for Influenza Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaccine for Influenza Major Market Trends
2 DEMAND SUMMARY
2.1 World Vaccine for Influenza Demand (2018-2029)
2.2 World Vaccine for Influenza Consumption by Region
2.2.1 World Vaccine for Influenza Consumption by Region (2018-2023)
2.2.2 World Vaccine for Influenza Consumption Forecast by Region (2024-2029)
2.3 United States Vaccine for Influenza Consumption (2018-2029)
2.4 China Vaccine for Influenza Consumption (2018-2029)
2.5 Europe Vaccine for Influenza Consumption (2018-2029)
2.6 Japan Vaccine for Influenza Consumption (2018-2029)
2.7 South Korea Vaccine for Influenza Consumption (2018-2029)
2.8 ASEAN Vaccine for Influenza Consumption (2018-2029)
2.9 India Vaccine for Influenza Consumption (2018-2029)
3 WORLD VACCINE FOR INFLUENZA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vaccine for Influenza Production Value by Manufacturer (2018-2023)
3.2 World Vaccine for Influenza Production by Manufacturer (2018-2023)
3.3 World Vaccine for Influenza Average Price by Manufacturer (2018-2023)
3.4 Vaccine for Influenza Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vaccine for Influenza Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vaccine for Influenza in 2022
3.5.3 Global Concentration Ratios (CR8) for Vaccine for Influenza in 2022
3.6 Vaccine for Influenza Market: Overall Company Footprint Analysis
3.6.1 Vaccine for Influenza Market: Region Footprint
3.6.2 Vaccine for Influenza Market: Company Product Type Footprint
3.6.3 Vaccine for Influenza Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vaccine for Influenza Production Value Comparison
4.1.1 United States VS China: Vaccine for Influenza Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Vaccine for Influenza Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Vaccine for Influenza Production Comparison
4.2.1 United States VS China: Vaccine for Influenza Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaccine for Influenza Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Vaccine for Influenza Consumption Comparison
4.3.1 United States VS China: Vaccine for Influenza Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Vaccine for Influenza Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Vaccine for Influenza Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vaccine for Influenza Production Value (2018-2023)
4.4.3 United States Based Manufacturers Vaccine for Influenza Production (2018-2023)
4.5 China Based Vaccine for Influenza Manufacturers and Market Share
4.5.1 China Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vaccine for Influenza Production Value (2018-2023)
4.5.3 China Based Manufacturers Vaccine for Influenza Production (2018-2023)
4.6 Rest of World Based Vaccine for Influenza Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vaccine for Influenza Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Vaccine for Influenza Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaccine for Influenza Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Trivalent Influenza Vaccine
5.2.2 Quadrivalent Influenza Vaccine
5.3 Market Segment by Type
5.3.1 World Vaccine for Influenza Production by Type (2018-2029)
5.3.2 World Vaccine for Influenza Production Value by Type (2018-2029)
5.3.3 World Vaccine for Influenza Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaccine for Influenza Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 6 Months to 3 Years
6.2.2 > 3 Years
6.3 Market Segment by Application
6.3.1 World Vaccine for Influenza Production by Application (2018-2029)
6.3.2 World Vaccine for Influenza Production Value by Application (2018-2029)
6.3.3 World Vaccine for Influenza Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Vaccine for Influenza Product and Services
7.1.4 Sanofi Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 CSL
7.2.1 CSL Details
7.2.2 CSL Major Business
7.2.3 CSL Vaccine for Influenza Product and Services
7.2.4 CSL Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CSL Recent Developments/Updates
7.2.6 CSL Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Vaccine for Influenza Product and Services
7.3.4 GSK Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Viatris
7.4.1 Viatris Details
7.4.2 Viatris Major Business
7.4.3 Viatris Vaccine for Influenza Product and Services
7.4.4 Viatris Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Viatris Recent Developments/Updates
7.4.6 Viatris Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Vaccine for Influenza Product and Services
7.5.4 AstraZeneca Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 Hualan Bio
7.6.1 Hualan Bio Details
7.6.2 Hualan Bio Major Business
7.6.3 Hualan Bio Vaccine for Influenza Product and Services
7.6.4 Hualan Bio Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hualan Bio Recent Developments/Updates
7.6.6 Hualan Bio Competitive Strengths & Weaknesses
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Details
7.7.2 Changchun Institute of Biological Major Business
7.7.3 Changchun Institute of Biological Vaccine for Influenza Product and Services
7.7.4 Changchun Institute of Biological Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun Institute of Biological Recent Developments/Updates
7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
7.8 Sinovac
7.8.1 Sinovac Details
7.8.2 Sinovac Major Business
7.8.3 Sinovac Vaccine for Influenza Product and Services
7.8.4 Sinovac Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Recent Developments/Updates
7.8.6 Sinovac Competitive Strengths & Weaknesses
7.9 BCHT
7.9.1 BCHT Details
7.9.2 BCHT Major Business
7.9.3 BCHT Vaccine for Influenza Product and Services
7.9.4 BCHT Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BCHT Recent Developments/Updates
7.9.6 BCHT Competitive Strengths & Weaknesses
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Details
7.10.2 Jiangsu GDK Major Business
7.10.3 Jiangsu GDK Vaccine for Influenza Product and Services
7.10.4 Jiangsu GDK Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jiangsu GDK Recent Developments/Updates
7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
7.11 KM Biologics
7.11.1 KM Biologics Details
7.11.2 KM Biologics Major Business
7.11.3 KM Biologics Vaccine for Influenza Product and Services
7.11.4 KM Biologics Vaccine for Influenza Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 KM Biologics Recent Developments/Updates
7.11.6 KM Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaccine for Influenza Industry Chain
8.2 Vaccine for Influenza Upstream Analysis
8.2.1 Vaccine for Influenza Core Raw Materials
8.2.2 Main Manufacturers of Vaccine for Influenza Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Vaccine for Influenza Production Mode
8.6 Vaccine for Influenza Procurement Model
8.7 Vaccine for Influenza Industry Sales Model and Sales Channels
8.7.1 Vaccine for Influenza Sales Model
8.7.2 Vaccine for Influenza Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Vaccine for Influenza Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Vaccine for Influenza Production Value by Region (2018-2023) & (USD Million)
Table 3. World Vaccine for Influenza Production Value by Region (2024-2029) & (USD Million)
Table 4. World Vaccine for Influenza Production Value Market Share by Region (2018-2023)
Table 5. World Vaccine for Influenza Production Value Market Share by Region (2024-2029)
Table 6. World Vaccine for Influenza Production by Region (2018-2023) & (M Units)
Table 7. World Vaccine for Influenza Production by Region (2024-2029) & (M Units)
Table 8. World Vaccine for Influenza Production Market Share by Region (2018-2023)
Table 9. World Vaccine for Influenza Production Market Share by Region (2024-2029)
Table 10. World Vaccine for Influenza Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Vaccine for Influenza Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Vaccine for Influenza Major Market Trends
Table 13. World Vaccine for Influenza Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Units)
Table 14. World Vaccine for Influenza Consumption by Region (2018-2023) & (M Units)
Table 15. World Vaccine for Influenza Consumption Forecast by Region (2024-2029) & (M Units)
Table 16. World Vaccine for Influenza Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Vaccine for Influenza Producers in 2022
Table 18. World Vaccine for Influenza Production by Manufacturer (2018-2023) & (M Units)
Table 19. Production Market Share of Key Vaccine for Influenza Producers in 2022
Table 20. World Vaccine for Influenza Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Vaccine for Influenza Company Evaluation Quadrant
Table 22. World Vaccine for Influenza Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Vaccine for Influenza Production Site of Key Manufacturer
Table 24. Vaccine for Influenza Market: Company Product Type Footprint
Table 25. Vaccine for Influenza Market: Company Product Application Footprint
Table 26. Vaccine for Influenza Competitive Factors
Table 27. Vaccine for Influenza New Entrant and Capacity Expansion Plans
Table 28. Vaccine for Influenza Mergers & Acquisitions Activity
Table 29. United States VS China Vaccine for Influenza Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Vaccine for Influenza Production Comparison, (2018 & 2022 & 2029) & (M Units)
Table 31. United States VS China Vaccine for Influenza Consumption Comparison, (2018 & 2022 & 2029) & (M Units)
Table 32. United States Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vaccine for Influenza Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Vaccine for Influenza Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Vaccine for Influenza Production (2018-2023) & (M Units)
Table 36. United States Based Manufacturers Vaccine for Influenza Production Market Share (2018-2023)
Table 37. China Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vaccine for Influenza Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Vaccine for Influenza Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Vaccine for Influenza Production (2018-2023) & (M Units)
Table 41. China Based Manufacturers Vaccine for Influenza Production Market Share (2018-2023)
Table 42. Rest of World Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Vaccine for Influenza Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Vaccine for Influenza Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Vaccine for Influenza Production (2018-2023) & (M Units)
Table 46. Rest of World Based Manufacturers Vaccine for Influenza Production Market Share (2018-2023)
Table 47. World Vaccine for Influenza Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Vaccine for Influenza Production by Type (2018-2023) & (M Units)
Table 49. World Vaccine for Influenza Production by Type (2024-2029) & (M Units)
Table 50. World Vaccine for Influenza Production Value by Type (2018-2023) & (USD Million)
Table 51. World Vaccine for Influenza Production Value by Type (2024-2029) & (USD Million)
Table 52. World Vaccine for Influenza Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Vaccine for Influenza Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Vaccine for Influenza Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Vaccine for Influenza Production by Application (2018-2023) & (M Units)
Table 56. World Vaccine for Influenza Production by Application (2024-2029) & (M Units)
Table 57. World Vaccine for Influenza Production Value by Application (2018-2023) & (USD Million)
Table 58. World Vaccine for Influenza Production Value by Application (2024-2029) & (USD Million)
Table 59. World Vaccine for Influenza Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Vaccine for Influenza Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Vaccine for Influenza Product and Services
Table 64. Sanofi Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. CSL Basic Information, Manufacturing Base and Competitors
Table 68. CSL Major Business
Table 69. CSL Vaccine for Influenza Product and Services
Table 70. CSL Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. CSL Recent Developments/Updates
Table 72. CSL Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Vaccine for Influenza Product and Services
Table 76. GSK Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Viatris Basic Information, Manufacturing Base and Competitors
Table 80. Viatris Major Business
Table 81. Viatris Vaccine for Influenza Product and Services
Table 82. Viatris Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Viatris Recent Developments/Updates
Table 84. Viatris Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Vaccine for Influenza Product and Services
Table 88. AstraZeneca Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Vaccine for Influenza Product and Services
Table 94. Hualan Bio Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 98. Changchun Institute of Biological Major Business
Table 99. Changchun Institute of Biological Vaccine for Influenza Product and Services
Table 100. Changchun Institute of Biological Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Changchun Institute of Biological Recent Developments/Updates
Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Major Business
Table 105. Sinovac Vaccine for Influenza Product and Services
Table 106. Sinovac Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sinovac Recent Developments/Updates
Table 108. Sinovac Competitive Strengths & Weaknesses
Table 109. BCHT Basic Information, Manufacturing Base and Competitors
Table 110. BCHT Major Business
Table 111. BCHT Vaccine for Influenza Product and Services
Table 112. BCHT Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BCHT Recent Developments/Updates
Table 114. BCHT Competitive Strengths & Weaknesses
Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu GDK Major Business
Table 117. Jiangsu GDK Vaccine for Influenza Product and Services
Table 118. Jiangsu GDK Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 121. KM Biologics Major Business
Table 122. KM Biologics Vaccine for Influenza Product and Services
Table 123. KM Biologics Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Vaccine for Influenza Upstream (Raw Materials)
Table 125. Vaccine for Influenza Typical Customers
Table 126. Vaccine for Influenza Typical Distributors
List of Figure
Figure 1. Vaccine for Influenza Picture
Figure 2. World Vaccine for Influenza Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaccine for Influenza Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 5. World Vaccine for Influenza Average Price (2018-2029) & (US$/Unit)
Figure 6. World Vaccine for Influenza Production Value Market Share by Region (2018-2029)
Figure 7. World Vaccine for Influenza Production Market Share by Region (2018-2029)
Figure 8. North America Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 9. Europe Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 10. China Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 11. Japan Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 12. Vaccine for Influenza Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 15. World Vaccine for Influenza Consumption Market Share by Region (2018-2029)
Figure 16. United States Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 17. China Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 18. Europe Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 19. Japan Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 20. South Korea Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 21. ASEAN Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 22. India Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 23. Producer Shipments of Vaccine for Influenza by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vaccine for Influenza Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vaccine for Influenza Markets in 2022
Figure 26. United States VS China: Vaccine for Influenza Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Vaccine for Influenza Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaccine for Influenza Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Vaccine for Influenza Production Market Share 2022
Figure 30. China Based Manufacturers Vaccine for Influenza Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Vaccine for Influenza Production Market Share 2022
Figure 32. World Vaccine for Influenza Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Vaccine for Influenza Production Value Market Share by Type in 2022
Figure 34. Trivalent Influenza Vaccine
Figure 35. Quadrivalent Influenza Vaccine
Figure 36. World Vaccine for Influenza Production Market Share by Type (2018-2029)
Figure 37. World Vaccine for Influenza Production Value Market Share by Type (2018-2029)
Figure 38. World Vaccine for Influenza Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Vaccine for Influenza Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Vaccine for Influenza Production Value Market Share by Application in 2022
Figure 41. 6 Months to 3 Years
Figure 42. > 3 Years
Figure 43. World Vaccine for Influenza Production Market Share by Application (2018-2029)
Figure 44. World Vaccine for Influenza Production Value Market Share by Application (2018-2029)
Figure 45. World Vaccine for Influenza Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Vaccine for Influenza Industry Chain
Figure 47. Vaccine for Influenza Procurement Model
Figure 48. Vaccine for Influenza Sales Model
Figure 49. Vaccine for Influenza Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Vaccine for Influenza Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Vaccine for Influenza Production Value by Region (2018-2023) & (USD Million)
Table 3. World Vaccine for Influenza Production Value by Region (2024-2029) & (USD Million)
Table 4. World Vaccine for Influenza Production Value Market Share by Region (2018-2023)
Table 5. World Vaccine for Influenza Production Value Market Share by Region (2024-2029)
Table 6. World Vaccine for Influenza Production by Region (2018-2023) & (M Units)
Table 7. World Vaccine for Influenza Production by Region (2024-2029) & (M Units)
Table 8. World Vaccine for Influenza Production Market Share by Region (2018-2023)
Table 9. World Vaccine for Influenza Production Market Share by Region (2024-2029)
Table 10. World Vaccine for Influenza Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Vaccine for Influenza Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Vaccine for Influenza Major Market Trends
Table 13. World Vaccine for Influenza Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (M Units)
Table 14. World Vaccine for Influenza Consumption by Region (2018-2023) & (M Units)
Table 15. World Vaccine for Influenza Consumption Forecast by Region (2024-2029) & (M Units)
Table 16. World Vaccine for Influenza Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Vaccine for Influenza Producers in 2022
Table 18. World Vaccine for Influenza Production by Manufacturer (2018-2023) & (M Units)
Table 19. Production Market Share of Key Vaccine for Influenza Producers in 2022
Table 20. World Vaccine for Influenza Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Vaccine for Influenza Company Evaluation Quadrant
Table 22. World Vaccine for Influenza Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Vaccine for Influenza Production Site of Key Manufacturer
Table 24. Vaccine for Influenza Market: Company Product Type Footprint
Table 25. Vaccine for Influenza Market: Company Product Application Footprint
Table 26. Vaccine for Influenza Competitive Factors
Table 27. Vaccine for Influenza New Entrant and Capacity Expansion Plans
Table 28. Vaccine for Influenza Mergers & Acquisitions Activity
Table 29. United States VS China Vaccine for Influenza Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Vaccine for Influenza Production Comparison, (2018 & 2022 & 2029) & (M Units)
Table 31. United States VS China Vaccine for Influenza Consumption Comparison, (2018 & 2022 & 2029) & (M Units)
Table 32. United States Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vaccine for Influenza Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Vaccine for Influenza Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Vaccine for Influenza Production (2018-2023) & (M Units)
Table 36. United States Based Manufacturers Vaccine for Influenza Production Market Share (2018-2023)
Table 37. China Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vaccine for Influenza Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Vaccine for Influenza Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Vaccine for Influenza Production (2018-2023) & (M Units)
Table 41. China Based Manufacturers Vaccine for Influenza Production Market Share (2018-2023)
Table 42. Rest of World Based Vaccine for Influenza Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Vaccine for Influenza Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Vaccine for Influenza Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Vaccine for Influenza Production (2018-2023) & (M Units)
Table 46. Rest of World Based Manufacturers Vaccine for Influenza Production Market Share (2018-2023)
Table 47. World Vaccine for Influenza Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Vaccine for Influenza Production by Type (2018-2023) & (M Units)
Table 49. World Vaccine for Influenza Production by Type (2024-2029) & (M Units)
Table 50. World Vaccine for Influenza Production Value by Type (2018-2023) & (USD Million)
Table 51. World Vaccine for Influenza Production Value by Type (2024-2029) & (USD Million)
Table 52. World Vaccine for Influenza Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Vaccine for Influenza Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Vaccine for Influenza Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Vaccine for Influenza Production by Application (2018-2023) & (M Units)
Table 56. World Vaccine for Influenza Production by Application (2024-2029) & (M Units)
Table 57. World Vaccine for Influenza Production Value by Application (2018-2023) & (USD Million)
Table 58. World Vaccine for Influenza Production Value by Application (2024-2029) & (USD Million)
Table 59. World Vaccine for Influenza Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Vaccine for Influenza Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Vaccine for Influenza Product and Services
Table 64. Sanofi Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. CSL Basic Information, Manufacturing Base and Competitors
Table 68. CSL Major Business
Table 69. CSL Vaccine for Influenza Product and Services
Table 70. CSL Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. CSL Recent Developments/Updates
Table 72. CSL Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Vaccine for Influenza Product and Services
Table 76. GSK Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Viatris Basic Information, Manufacturing Base and Competitors
Table 80. Viatris Major Business
Table 81. Viatris Vaccine for Influenza Product and Services
Table 82. Viatris Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Viatris Recent Developments/Updates
Table 84. Viatris Competitive Strengths & Weaknesses
Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Major Business
Table 87. AstraZeneca Vaccine for Influenza Product and Services
Table 88. AstraZeneca Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Recent Developments/Updates
Table 90. AstraZeneca Competitive Strengths & Weaknesses
Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 92. Hualan Bio Major Business
Table 93. Hualan Bio Vaccine for Influenza Product and Services
Table 94. Hualan Bio Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hualan Bio Recent Developments/Updates
Table 96. Hualan Bio Competitive Strengths & Weaknesses
Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 98. Changchun Institute of Biological Major Business
Table 99. Changchun Institute of Biological Vaccine for Influenza Product and Services
Table 100. Changchun Institute of Biological Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Changchun Institute of Biological Recent Developments/Updates
Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Major Business
Table 105. Sinovac Vaccine for Influenza Product and Services
Table 106. Sinovac Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sinovac Recent Developments/Updates
Table 108. Sinovac Competitive Strengths & Weaknesses
Table 109. BCHT Basic Information, Manufacturing Base and Competitors
Table 110. BCHT Major Business
Table 111. BCHT Vaccine for Influenza Product and Services
Table 112. BCHT Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BCHT Recent Developments/Updates
Table 114. BCHT Competitive Strengths & Weaknesses
Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 116. Jiangsu GDK Major Business
Table 117. Jiangsu GDK Vaccine for Influenza Product and Services
Table 118. Jiangsu GDK Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 121. KM Biologics Major Business
Table 122. KM Biologics Vaccine for Influenza Product and Services
Table 123. KM Biologics Vaccine for Influenza Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Vaccine for Influenza Upstream (Raw Materials)
Table 125. Vaccine for Influenza Typical Customers
Table 126. Vaccine for Influenza Typical Distributors
List of Figure
Figure 1. Vaccine for Influenza Picture
Figure 2. World Vaccine for Influenza Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaccine for Influenza Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 5. World Vaccine for Influenza Average Price (2018-2029) & (US$/Unit)
Figure 6. World Vaccine for Influenza Production Value Market Share by Region (2018-2029)
Figure 7. World Vaccine for Influenza Production Market Share by Region (2018-2029)
Figure 8. North America Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 9. Europe Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 10. China Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 11. Japan Vaccine for Influenza Production (2018-2029) & (M Units)
Figure 12. Vaccine for Influenza Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 15. World Vaccine for Influenza Consumption Market Share by Region (2018-2029)
Figure 16. United States Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 17. China Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 18. Europe Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 19. Japan Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 20. South Korea Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 21. ASEAN Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 22. India Vaccine for Influenza Consumption (2018-2029) & (M Units)
Figure 23. Producer Shipments of Vaccine for Influenza by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vaccine for Influenza Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vaccine for Influenza Markets in 2022
Figure 26. United States VS China: Vaccine for Influenza Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Vaccine for Influenza Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaccine for Influenza Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Vaccine for Influenza Production Market Share 2022
Figure 30. China Based Manufacturers Vaccine for Influenza Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Vaccine for Influenza Production Market Share 2022
Figure 32. World Vaccine for Influenza Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Vaccine for Influenza Production Value Market Share by Type in 2022
Figure 34. Trivalent Influenza Vaccine
Figure 35. Quadrivalent Influenza Vaccine
Figure 36. World Vaccine for Influenza Production Market Share by Type (2018-2029)
Figure 37. World Vaccine for Influenza Production Value Market Share by Type (2018-2029)
Figure 38. World Vaccine for Influenza Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Vaccine for Influenza Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Vaccine for Influenza Production Value Market Share by Application in 2022
Figure 41. 6 Months to 3 Years
Figure 42. > 3 Years
Figure 43. World Vaccine for Influenza Production Market Share by Application (2018-2029)
Figure 44. World Vaccine for Influenza Production Value Market Share by Application (2018-2029)
Figure 45. World Vaccine for Influenza Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Vaccine for Influenza Industry Chain
Figure 47. Vaccine for Influenza Procurement Model
Figure 48. Vaccine for Influenza Sales Model
Figure 49. Vaccine for Influenza Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
